BOSTON & LEUVEN, Belgium--(BUSINESS WIRE)--
Cartagenia, the world leader in providing genetic labs and clinicians with software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, today announced that more than 120 labs and clinics across three continents have now adopted and are relying on its Bench platform genetics diagnostics solution for use in daily practice. Bench is a web-based software and database platform with features and knowledge sources that allows clinicians to analyze, interpret and manage genomic variations in routing diagnostics.
Cartagenia CEO Herman Verrelst said the marked success of the Bench platform underscores a true need for clinical grade tools for lab variant assessment and reporting support in the rapidly expanding world of genetic diagnostics.
It is very rewarding to see the enthusiastic response we are receiving for our Bench solutions in all our key markets and across three continents, Verrelst said. We believe this reflects very strong growth in NGS adoption and a clear need for diagnostic-grade solutions in lab interpretation and reporting workflow automation, integration with the referring physician and hospital IT, and linking to the community through data sharing initiatives all tools that Cartagenia Bench platform provides.
Cartagenia also announced that it has released a new version of its Bench Lab NGS module, the powerful software and database solution for robust and reliable NGS variant analysis, interpretation and reporting pipelines.
The new version of the NGS module is focused on increasing a labs efficiency through faster report generation and has added:
Greenwood Genetic Center, a South Carolina-based, non-profit institute that provides genetic services and diagnostic laboratory testing, adopted Bench Lab NGS in 2012. Mike Friez, Greenwoods Director of Diagnostic Laboratories, noted that his lab generates DNA sequencing data on large portions of the genome and Cartagenias Bench Lab product facilitates the sorting, filtering and organization of these data.
Implementing the Cartagenia Bench Lab NGS platform has significantly impacted our ability to effectively manage and interpret data for our targeted NGS panels as well as the exomes generated from our undiagnosed patients, Friez said. By pooling a variety of powerful resources, Cartagenia really does enable us to make progress in assisting the families we serve.
Jean-Louis Mandel, Professor of Genetics at the Faculty of Medicine of Strasbourg, France, and Head of the Human Molecular Genetic Group at the IGBMC, noted that he is impressed by the collaborative approach set up with Cartagenia.
We have seen the Bench Lab NGS platform evolve rapidly over the period of time weve worked with Cartagenia to evaluate the software and run it on our own research and diagnostic samples, Prof. Mandel said. Cartagenia speaks the language of clinical geneticists, and Im looking forward to having many fruitful and constructive discussions that will undoubtedly lead to yet more new analysis and interpretation support features of wide interest.
Continued here:
Cartagenia Announces More Than 120 Labs and Clinics Globally Now Relying on Its Bench Platform for Routine Genetic ...